Prenatal genetic diagnosis of Down's syndrome

Area of Science:

• Genetics and Obstetrics
• Prenatal diagnostics

Background:

• Down's syndrome is a frequent cause of congenital abnormalities and intellectual disability.
• Increased maternal age is a significant risk factor for Down's syndrome pregnancies.
• Prenatal detection is crucial for informed pregnancy management and fetal health.

Purpose of the Study:

• To outline current prenatal screening and diagnostic approaches for Down's syndrome.
• To highlight the importance of these methods, especially for advanced maternal age pregnancies.
• To discuss the evolution towards safer and more informative diagnostic techniques.

Main Methods:

• Prenatal screening utilizes maternal age, serum markers, and fetal ultrasound in the first and second trimesters.
• Definitive diagnosis is achieved through invasive procedures like amniocentesis or chorionic villus sampling.
• Molecular genetic techniques are increasingly used alongside traditional chromosome analysis.

Main Results:

• Screening tests identify pregnancies at increased risk for Down's syndrome.
• Invasive diagnostic tests provide definitive confirmation.
• Molecular genetics offers broader disorder identification and earlier results.

Conclusions:

• Current prenatal screening and diagnostic methods are vital for managing Down's syndrome.
• There is an ongoing need for safer, non-invasive methods for fetal cell acquisition.
• Advancements in molecular genetics are improving the scope and timeliness of prenatal genetic testing.